AMGN

Amgen
D

AMGN

272.25
USD
2.84
(1.05%)
Market Closed
Volume
118,259
EPS
21
Div Yield
3.34
P/E
35
Market Cap
146,343,283,837
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    ABBV
    -2.210
    (-1.27%)
    171.520 USD
    BIIB
    BIIB
    -0.660
    (-0.47%)
    140.580 USD
    BMY
    BMY
    -0.100
    (-0.18%)
    56.300 USD
    GILD
    GILD
    0.150
    (0.16%)
    91.790 USD
    JNJ
    JNJ
    -0.740
    (-0.50%)
    147.060 USD
    MRK
    MRK
    -2.790
    (-2.77%)
    97.940 USD
    PFE
    PFE
    -0.195
    (-0.74%)
    26.305 USD
    REGN
    REGN
    -11.37
    (-1.64%)
    681.49 USD
    More
News

Title: Amgen

Sector: Healthcare
Industry: Drug Manufacturers - General
Amgen Inc. is an American global biopharmaceutical company that engages in the development, manufacture and marketing of human therapeutics. It is headquartered in Thousand Oaks, California. The company has deep interests in molecular biology and biochemistry, which underpin its goal to provide human care based on recombinant DNA technology. Some of the company’s best-performing products include Neulasta and Enbrel. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.